文献速递心脑血管急症重症综合管理与镇静镇痛

撤除生命维持治疗对心脏骤停后长期神经功能结局的影响:一项多中心匹配队列研究

Effects of withdrawal of life-sustaining therapy on long-term neurological outcome after cardiac arrest - A multicentre matched cohort study.
PubMed 文献 · Resuscitation · 2025-08-07
一句话结论至少2项ERC/ESICM不良预后标准者,WLST自我实现预言风险可忽略;预后不确定者WLST与良好功能结局可能性降低相关。

该研究为多中心事后分析,将允许WLST队列(TTM和TTM2)与不允许WLST队列(KORHN和ProNeCA)的院外心脏骤停复苏后昏迷成人按倾向评分1:1匹配,评估因推测不良神经预后而WLST的自我实现预言风险,并比较6个月功能结局。共纳入1717例,497例(29%)因神经标准在中位143小时(IQR 108-177)行WLST;其中303例(61%)回顾性符合≥2项ERC/ESICM不良预后标准。符合≥2项标准者无论WLST队列还是匹配对照,6个月均无良好功能结局。预后不确定(≤1项标准)者中,WLST队列仅1例(0.3%)有良好功能结局,而匹配对照为18-26%。探索性加权估计显示,若未行WLST,最多18%预后不确定者可能存活且功能结局良好。

要点

  • 至少2项ERC/ESICM不良预后标准者,WLST队列与匹配对照6个月均无良好功能结局,自我实现预言风险可忽略。
  • 预后不确定(≤1项ERC/ESICM标准)者,WLST队列良好功能结局仅1例(0.3%),匹配对照为18-26%。
  • 探索性加权估计提示,若未行WLST,最多18%预后不确定者可能存活且功能结局良好。
  • WLST因神经标准发生的中位时间为143小时(IQR 108-177),497例(29%)发生WLST。
  • 303例(61%)WLST患者回顾性符合≥2项ERC/ESICM不良预后标准。

适用人群与场景

  • 院外心脏骤停复苏后昏迷的成人,来自允许WLST的队列(TTM和TTM2)与不允许WLST的队列(KORHN和ProNeCA)。

诊断标准与关键阈值

  • 采用2021年ERC/ESICM指南中预测不良神经预后的标准;预后不确定定义为≤1项ERC/ESICM标准,不良预后标准为≥2项ERC/ESICM标准。

研究设计与关键结果

  • 多中心事后匹配队列研究,纳入1717例,497例(29%)因神经标准行WLST,中位时间143小时(IQR 108-177)。
  • 303例(61%)WLST患者回顾性符合≥2项ERC/ESICM不良预后标准。
  • 符合≥2项ERC/ESICM标准者,WLST队列与匹配对照6个月均无良好功能结局。
  • 预后不确定(≤1项标准)者中,WLST队列1例(0.3%)有良好功能结局,匹配对照为18-26%。
  • 探索性加权估计显示,若未行WLST,最多18%预后不确定者可能存活且功能结局良好。

证据类型、等级与局限

  • 证据类型:多中心事后匹配队列研究(post-hoc multicentre study)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,至少2项ERC/ESICM不良预后标准者,WLST自我实现预言风险可忽略;预后不确定者,WLST与良好功能结局可能性降低相关。

指南或共识出处

  • 2021年欧洲复苏委员会/欧洲重症医学会(ERC/ESICM)指南。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To assess the risk of self-fulfilling prophecy from withdrawal of life-sustaining therapy (WLST) in comatose cardiac arrest patients undergoing neuroprognostication.

METHODS: Post-hoc multicentre study matching adults resuscitated from out-of-hospital cardiac arrests, in WLST-permitting cohorts (TTM and TTM2), and non-WLST-permitting cohorts (KORHN and ProNeCA). We matched patients in a 1:1 ratio based on a propensity score, assessing the risk of WLST due to a presumed poor neurological prognosis and criteria predictive of poor neurological outcome, as outlined in the 2021 European Resuscitation Council/European Society of Intensive Care Medicine (ERC/ESICM) guidelines. Functional outcome was compared at six months.

RESULTS: We included 1717 patients, of whom 497 (29 %) had WLST due to neurological criteria at a median of 143 h (IQR 108-177). 303 (61 %) patients with WLST retrospectively fulfilled ≥ 2 ERC/ESICM criteria predictive of poor outcome. No patients with ≥ 2 ERC/ESICM criteria had good functional outcome at six months, neither in the WLST cohort nor among the matched controls. One patient (0.3 %) with an indeterminate prognosis (≤1 ERC/ESICM criteria) had a good functional outcome in the WLST cohort versus 18-26 % of the matched controls. In exploratory weighted estimates, up to 18 % of patients with indeterminate prognosis may have survived with a good functional outcome, if WLST had not occurred.

CONCLUSION: In patients with at least 2 ERC/ESICM criteria predictive of poor outcome, the risk of self-fulfilling prophecy from WLST was negligible. However, in patients with an indeterminate prognosis, the practice of WLST was associated with a lower likelihood of good functional outcome.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Lagebrant A, Lee BK, Youn CS, et al. Effects of withdrawal of life-sustaining therapy on long-term neurological outcome after cardiac arrest - A multicentre matched cohort study. Resuscitation. 2025. PMID: 40754263. doi:10.1016/j.resuscitation.2025.110747

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。